[Retracted] Establishment of a Nomogram Model for Predicting Cardiovascular and Cerebrovascular Events in Diabetic Nephropathy Patients Receiving Maintenance Hemodialysis

Table 1

Comparison of clinical data between the occurrence group and the nonoccurrence group.

Clinical data	Occurrence group ()	Nonoccurrence group ()	value	value
Gender (%)
Male	36 (57.14)	51 (62.96)	0.502	0.479
Female	27 (42.86)	30 (37.04)
Age (years old)			3.160	0.002
BMI (kg/m^2)			0.910	0.364
Course of diabetes			1.327	0.187
Course of diabetic nephropathy (months)			0.594	0.553
History of cardiovascular and cerebrovascular diseases
Yes	35 (55.56)	31 (38.27)	4.264	0.039
No	28 (44.44)	50 (61.73)
Smoking history
Yes	33 (52.38)	49 (60.49)	0.951	0.329
No	30 (47.62)	32 (39.51)
Systolic blood pressure (mmHg)			2.940	0.004
Diastolic blood pressure (mmHg)			1.036	0.302
Dialysis age (months)
≤12	15 (23.81)	50 (61.73)	20.576	<0.001
>12	48 (76.19)	31 (38.27)
Serum phosphorus (mmol/L)			2.268	0.025
TG (mmol/L)			2.531	0.012
ADPN (mg/L)
≥5	27 (42.86)	51 (62.96)	5.770	0.016
<5	36 (57.14)	30 (37.04)
hs-CRP (mg/L)			21.297	<0.001
Hb (g/L)			5.909	<0.001
SCr (μmol/L)			11.294	<0.001
ALB (g/L)			3.075	0.003